PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Oral administration of Yamabushitake significantly increased scores on a cognitive function scale compared to placebo over 16 weeks [PMID:18844328].
Oral intake of H. erinaceus significantly improved cognitive functions and prevented deterioration as measured by the Mini Mental State Examination (MMSE) over 12 weeks [PMID:31413233].
A single dose (1.8 g) resulted in quicker performance on the Stroop task at 60 minutes post-dose [PMID:38004235].
Intake of H. erinaceus cookies for 4 weeks significantly lowered scores on the Center for Epidemiologic Studies Depression Scale (CES-D) and the Indefinite Complaints Index (ICI) [PMID:20834180].
A trend towards reduced subjective stress was observed following 28-day supplementation of 1.8 g [PMID:38004235].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 37958943 (2023) — Neurotrophic and Neuroprotective Effects of Hericium erinaceus. · International journal of molecular sciences
- 2.PMID: 40284172 (2025) — Lion's Mane Mushroom (Hericium erinaceus): A Neuroprotective Fungus with Antioxidant, Anti-Inflammatory, and Antimicrobial Potential-A Narrative Review. · Nutrients
- 3.PMID: 38004235 (2023) — The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study. · Nutrients
- 4.PMID: 31413233 (2019) — Improvement of cognitive functions by oral intake of Hericium erinaceus. · Biomedical research (Tokyo, Japan)
- 5.PMID: 31881712 (2019)